Compare Medpace Holdings Inc (MEDP) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs PayPal Holdings, Inc. — how do they compare? Medpace Holdings Inc trades at $600.54 (market cap $16.90B), while PayPal Holdings, Inc. trades at $58.33 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 3× Medpace Holdings Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PYPL | |
|---|---|---|
Market Cap | $16.90B | $50.47B |
Sector | Technology | Financials |
52-Week High | $620.59 | $76.13 |
52-Week Low | $393.42 | $39.08 |
Enterprise Value | $16.52B | $52.62B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
PayPal trades at $59.07, showing stability with no recent price change. The stock exhibits bullish technical signals with strong moving average support and trades near key resistance at $60. Fundamentally, PayPal delivered Q2 2026 earnings beat with $1.38 EPS versus $1.28 expected, while revenue grew to $33.17 billion in 2025 with improving profit margins. Recent news highlights acquisition interest and strategic partnerships expanding payment capabilities.
PayPal presents a compelling value opportunity with attractive valuation multiples (P/E 11.15, P/S 1.6) and strong cash flow generation ($6.42B operating cash flow). However, risks include competitive pressures in digital payments and execution challenges under new leadership. Analyst consensus leans neutral with 60% hold ratings, though the $58.75 price target suggests limited upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
